Kenneth Samet Purchases 23,500 Shares of AdaptHealth (NASDAQ:AHCO) Stock

Posted by Brian Himes on Aug 12th, 2026

AdaptHealth Corp. (NASDAQ:AHCO – Get Free Report) Director Kenneth Samet purchased 23,500 shares of the company’s stock in a transaction dated Thursday, August 6th. The shares were purchased at an average cost of $6.38 per share, for a total transaction of $149,930.00. Following the transaction, the director directly owned 48,569 shares in the company, valued at approximately $309,870.22. This represents a 93.74% increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link.

AdaptHealth Stock Performance

Shares of AdaptHealth stock opened at $5.65 on Wednesday. The company has a current ratio of 1.12, a quick ratio of 0.98 and a debt-to-equity ratio of 1.37. The stock’s fifty day moving average price is $9.79 and its 200-day moving average price is $10.48. The firm has a market cap of $767.92 million, a P/E ratio of -3.30, a P/E/G ratio of 0.27 and a beta of 1.47. AdaptHealth Corp. has a 12 month low of $5.21 and a 12 month high of $13.43.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently commented on AHCO shares. Robert W. Baird set a $10.00 price target on shares of AdaptHealth in a report on Wednesday, August 5th. Truist Financial dropped their price objective on shares of AdaptHealth from $14.00 to $9.00 and set a “buy” rating on the stock in a research note on Wednesday, August 5th. Jefferies Financial Group raised shares of AdaptHealth from a “hold” rating to a “buy” rating and lifted their price objective for the company from $11.00 to $13.00 in a report on Tuesday, July 21st. UBS Group lowered their target price on AdaptHealth from $14.00 to $10.00 and set a “buy” rating for the company in a report on Thursday, August 6th. Finally, Wall Street Zen cut AdaptHealth from a “buy” rating to a “hold” rating in a research report on Saturday. Seven equities research analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat.com, AdaptHealth currently has a consensus rating of “Moderate Buy” and a consensus target price of $10.29.

Read Our Latest Stock Analysis on AHCO

Key AdaptHealth News

Here are the key news stories impacting AdaptHealth this week:

Positive Sentiment: Director Kenneth Samet purchased 23,500 shares at an average price of $6.38, investing approximately $149,930 and nearly doubling his direct ownership. The transaction may be viewed as a sign of management confidence after the stock’s sharp decline. Kenneth Samet Buys 23,500 Shares of AdaptHealth Stock
Positive Sentiment: AdaptHealth’s second-quarter earnings call and follow-up analyst coverage keep attention focused on management’s operating outlook and responses to questions about growth, profitability and execution. The company maintains broad analyst support, with seven Buy ratings and a reported consensus rating of Moderate Buy. AdaptHealth Q2 2026 Earnings Call Transcript
Neutral Sentiment: A report showing zero reported short interest and zero days to cover provides no meaningful evidence of short-covering demand; the figures may reflect incomplete or erroneous data rather than a genuine market-positioning change.
Negative Sentiment: Analysts have sharply reduced their valuation targets: Truist cut its target from $14 to $9, while UBS lowered its target from $14 to $10. Although both retained Buy ratings, the revisions signal greater caution about AdaptHealth’s near-term earnings outlook. The average target remains approximately $10.29, implying potential upside but also highlighting the gap between expectations and the current valuation. AdaptHealth Analyst Ratings

Institutional Trading of AdaptHealth

A number of institutional investors have recently modified their holdings of AHCO. Rockefeller Capital Management L.P. raised its stake in shares of AdaptHealth by 433.0% during the 4th quarter. Rockefeller Capital Management L.P. now owns 2,585 shares of the company’s stock worth $26,000 after acquiring an additional 2,100 shares in the last quarter. PNC Financial Services Group Inc. boosted its stake in AdaptHealth by 22.3% in the fourth quarter. PNC Financial Services Group Inc. now owns 7,003 shares of the company’s stock valued at $70,000 after acquiring an additional 1,279 shares in the last quarter. Assetmark Inc. boosted its stake in AdaptHealth by 54.8% in the first quarter. Assetmark Inc. now owns 6,952 shares of the company’s stock valued at $83,000 after acquiring an additional 2,460 shares in the last quarter. Tower Research Capital LLC TRC grew its holdings in AdaptHealth by 318.0% in the second quarter. Tower Research Capital LLC TRC now owns 9,592 shares of the company’s stock worth $90,000 after purchasing an additional 7,297 shares during the last quarter. Finally, Tidal Investments LLC purchased a new position in AdaptHealth in the second quarter worth $96,000. 82.67% of the stock is currently owned by institutional investors.

About AdaptHealth

(Get Free Report)

AdaptHealth, Inc operates as a leading provider of home medical equipment (HME) and related services in the United States. The company focuses on delivering respiratory care, mobility solutions and bathroom safety products to patients with chronic and acute medical needs. Through its comprehensive service offerings, AdaptHealth aims to enhance quality of life and clinical outcomes for patients who require long-term support outside of a hospital setting.

The company’s respiratory portfolio includes products such as continuous positive airway pressure (CPAP) devices, oxygen concentrators, ventilators, and associated supplies for patients with sleep apnea, COPD and other pulmonary conditions.